KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86.
Share this article
Markets
Score 35
Neutral
KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86
Mar 11, 2026 18:36 UTC
KALV, SPY
Short term
Related Articles
Score 25
Is Cogent Biosciences (COGT) One of the Best Multibagger Stocks to Buy According to Billionaires?
Mar 14, 18:29
Score 65
Bullish
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference
Mar 14, 18:02
Score 35
The Bull Case and Bear Case for CoreWeave Stock Right Now
Mar 14, 16:35
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.